NORMAL SITUATION

BK Medical Benelux

Export PDF

Company — Normal situation.

Financial year 2024 · Closed on 01/10/2024

Net result1,4 M €+595,0 %over 1 year

Revenue2,6 M €-44,3 %over 1 year

Equity3,4 M €+74,6 %over 1 year

Workforce7,9 ETP-9,2 %over 1 year

Identity

Source · BCE/KBO

BK Medical Benelux is a company registered in Belgium. It employs on average 7,9 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0447.494.751
Legal form: Public limited company
Contributed capital: 62 000,00 €
Latest accounts: 01/10/2024
Average workforce: 7,9 ETP

Joint committees (2)

Signals

ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 32 filings

Trend over 18 financial years

	2024		2023		2022		2021		2020
Income statement
Revenue	2,6 M €	-44.3%	4,8 M €	-22.3%	6,1 M €	+50.0%	4,1 M €	+4.6%	3,9 M €
EBITDA	1,7 M €	+632%	227,2 k €	-36.7%	359 k €	+7.9%	332,8 k €	+14.5%	290,6 k €
Operating result	1,6 M €	+645%	221,1 k €	-36.7%	349,5 k €	+100%	174,7 k €	+0.4%	174,1 k €
Net result	1,4 M €	+595%	208,1 k €	-37.9%	335,2 k €	+104%	164,1 k €	+4.0%	157,8 k €
Balance sheet
Equity	3,4 M €	+74.6%	1,9 M €	+12.0%	1,7 M €	+24.0%	1,4 M €	+13.3%	1,2 M €
Total assets	4 M €	+52.4%	2,6 M €	+17.1%	2,2 M €	-4.1%	2,3 M €	+14.9%	2 M €
Cash	2,6 M €	+570%	392,7 k €	-33.2%	587,7 k €	+304%	145,3 k €	+9.2%	133,1 k €
Debts	373,9 k €	-8.3%	407,8 k €	+48.0%	275,5 k €	-59.1%	673,5 k €	+21.8%	552,8 k €
Other
Workforce	7,9 ETP	-9.2%	8,7 ETP	+3.6%	8,4 ETP	0.0%	8,4 ETP	-10.6%	9,4 ETP

Board of directors

Source · NBB, accounts to 01/10/2024

3 active · 31 ended

Active mandates

Kristof Callebaut

Managing director · since 11 mai 2022 · until 11 mai 2028

Active

Joris Brauns

Managing director · since 01 août 2020 · until 31 juillet 2026

Active

Daniel Banemann

Director · since 01 novembre 2019 · until 31 octobre 2025

Active

Ended mandates

Joris Brauns

Director · since 01 août 2020 · until 31 juillet 2026

Ended

Brooks West

Director · since 03 août 2018 · until 02 août 2024

Ended

Brooks WEST

Director · since 03 août 2018 · until 11 mai 2022

Ended

Dave Hall

Director · since 22 juin 2018 · until 31 octobre 2019

Ended

Full financial information

Source · NBB

	2024	2023	2022	2021	2020	2019
Type of account	Abridged model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2024	01/01/2023	01/08/2021	01/08/2020	01/08/2019	01/08/2018
Closing of the financial year	01/10/2024	31/12/2023	31/12/2022	31/07/2021	31/07/2020	31/07/2019
Length of the financial year	10 months	12 months	17 months	12 months	12 months	12 months
Filing date	18/03/2025	25/06/2024	13/06/2023	09/11/2021	09/11/2020	19/11/2019
General meeting	13/03/2025	29/05/2024	31/05/2023	29/10/2021	30/10/2020	25/10/2019
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 32 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	01/10/2024	13/03/2025	18/03/2025	Dutch	PDF
Full model	31/12/2023	29/05/2024	25/06/2024	Dutch	PDF
Full model	31/12/2022	31/05/2023	13/06/2023	Dutch	PDF
Full model	31/07/2021	29/10/2021	09/11/2021	Dutch	PDF
Full model	31/07/2020	30/10/2020	09/11/2020	Dutch	PDF
Full model	31/07/2019	25/10/2019	19/11/2019	Dutch	PDF
Full model	31/07/2018	26/10/2018	12/11/2018	Dutch	PDF
Full model	31/07/2017	27/10/2017	23/11/2017	Dutch	PDF
Full model	31/07/2016	28/10/2016	24/11/2016	Dutch	PDF
Full model	31/07/2015	30/10/2015	10/11/2015	Dutch	PDF
Full model	31/07/2014	31/10/2014	18/12/2014	Dutch	PDF
Full model	31/07/2013	25/10/2013	08/11/2013	Dutch	PDF
Full model	31/07/2012	26/10/2012	06/11/2012	Dutch	PDF
Full model	31/07/2011	28/10/2011	07/11/2011	Dutch	PDF
Full model	31/07/2010	29/10/2010	04/11/2010	Dutch	PDF
Full model	31/07/2009	30/10/2009	04/11/2009	Dutch	PDF
Full model	31/07/2008	31/10/2008	18/11/2008	Dutch	PDF
Full model	31/07/2007	26/10/2007	10/12/2007	Dutch	PDF
Full model	31/07/2006	27/10/2006	08/12/2006	Dutch	PDF
Full model	31/07/2005	28/10/2005	13/02/2006	Dutch	PDF
Full model	31/07/2004	29/10/2004	28/01/2005	Dutch	PDF
Full model	31/07/2003	31/10/2003	11/02/2004	Dutch	PDF
Full model	31/07/2002	25/10/2002	12/02/2003	Dutch	PDF
Full model	31/07/2001	26/10/2001	07/12/2001	Dutch	PDF

View all 32 filings

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 01/10/2024

3 active · 31 ended

Active mandates

Kristof Callebaut

Managing director · since 11 mai 2022 · until 11 mai 2028

Active

Joris Brauns

Managing director · since 01 août 2020 · until 31 juillet 2026

Active

Daniel Banemann

Director · since 01 novembre 2019 · until 31 octobre 2025

Active

Ended mandates

Joris Brauns

Director · since 01 août 2020 · until 31 juillet 2026

Ended

Brooks West

Director · since 03 août 2018 · until 02 août 2024

Ended

Brooks WEST

Director · since 03 août 2018 · until 11 mai 2022

Ended

Dave Hall

Director · since 22 juin 2018 · until 31 octobre 2019

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Dissolution22/10/2024
RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ... - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Capital / shares14/10/2024
KAPITAAL - AANDELEN
PDF
Restructuring29/08/2024
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Mandates26/03/2024
ONTSLAGEN - BENOEMINGEN
PDF
Other08/08/2022
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ALGEMENE VERGADERING - BOEKJAAR
PDF
Mandates06/07/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates23/02/2021
ONTSLAGEN - BENOEMINGEN
PDF
Other26/11/2020
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2024
Annual accounts 20241,4 M €↑
2023
Annual accounts 2023208,1 k €↓
2022
Annual accounts 2022335,2 k €↑
2021
Annual accounts 2021164,1 k €↑
2020
Annual accounts 2020157,8 k €↓
2019
Annual accounts 2019170,6 k €↑
2018
Annual accounts 2018148,1 k €↑
2017
Annual accounts 2017125 k €↑
2016
Annual accounts 201694,3 k €↑
2015
Annual accounts 201561,1 k €↑
2014
Annual accounts 201446,8 k €↓
2013
Annual accounts 201387 k €↑
2012
Annual accounts 201259,6 k €↓
2011
Annual accounts 201170,3 k €↑
2010
Annual accounts 201062 k €↑
2009
Annual accounts 200960 k €↑
2008
Annual accounts 200836,1 k €↑
2007
Annual accounts 2007-9,3 k €

BK Medical Benelux

Overview

Identity

Financials

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline